‘Anxiety Cells’ Identified in the Brain’s Hippocampus
Neuroscientists at Columbia University Medical Center and the University of California, San Francisco, have found in mice that certain brain cells in the hippocampus fire when the animal is anxious, triggering anxiety-related behaviors.
Opioid Overdose Survivors Face Higher Death Rate
Researchers at NewYork-Presbyterian/Columbia have found opioid overdose survivors are at great risk of dying from respiratory diseases, viral hepatitis, and suicide in the year after an overdose, according to a report published in JAMA Psychiatry.
Online Databases: A Prescription for the Opioid Epidemic
As drug overdoses continue to rise in the United States, doctors and policymakers search for solutions to stem the tide of opioid-related deaths. Researchers at NewYork-Presbyterian/Weill Cornell are studying the efficacy of statewide online databases to track prescriptions.
Orthopedics: A Focus on Faculty 2019 Issue 1
A Focus on Faculty: Highlighting a Range of Expertise in Orthopedics
The Perry Initiative: Encouraging Young Women to Enter Orthopedics
Women make up only 6.1% of US orthopedic surgeons. The Columbia University Department of Orthopedic Surgery partnered with The Perry Initiative to host an outreach program for 39 high school students to increase the pool of women who might be interested in the field.
Center for Athletic Hip Injuries and Hip Preservation
In recent years it has been shown that younger athletic adults are also prone to hip problems that were once considered merely groin or muscle injuries. At the Center for Athletic Hip Injuries and Hip Preservation at NewYork-Presbyterian/Columbia, doctors are focused on providing joint-preserving treatment for young, active adults.
Glaucoma: Accelerating Genetic Discoveries for Clinical Applications
With the support of a major award from The Brown Foundation, Dr. Jeffrey M. Liebmann and his team have launched the Brown Glaucoma Genetics Initiative, a continuum of investigative and therapeutic projects with the aim of developing treatments for specific subtypes of the disease.
Manuel Hidalgo, MD, PhD: A Pioneer in Pancreatic Cancer
For more than two decades, Dr. Manuel Hidalgo has pursued laboratory and clinical research with a major focus on drug development in pancreatic cancer.
Page1 of 6